Barbara Ann Karmanos Cancer Center — Detroit, Michigan

Barbara Ann Karmanos Cancer Center is a clinical research site located in Detroit, Michigan, United States.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Barbara Ann Karmanos Cancer Center has participated in 18 clinical trials with 4 currently active.

Therapeutic areas: Advanced Cancer, Advanced Malignancies, Advanced Malignancies, Non-small Cell Lung Cancer.

Sponsors: Regeneron Pharmaceuticals, Mirati Therapeutics Inc., Jounce Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Barbara Ann Karmanos Cancer Center?

Barbara Ann Karmanos Cancer Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Barbara Ann Karmanos Cancer Center conducted?

Barbara Ann Karmanos Cancer Center has 18 clinical trials on record, with 4 currently active. Their work covers Advanced Cancer, Advanced Malignancies, Advanced Malignancies, Non-small Cell Lung Cancer.

Is Barbara Ann Karmanos Cancer Center accredited by Crixeo Health?

Yes — Barbara Ann Karmanos Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Barbara Ann Karmanos Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.